RCAS1 Expression: A Potential Prognostic Marker for Adenocarcinomas of the Lung

Identification and characterization of a new member of the TNF family that induces apoptosis

1995 • 2,890 citations

Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege

1995 • 2,028 citations

Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family

1996 • 1,793 citations

Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

1996 • 1,281 citations

Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?

1996 • 917 citations

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

1998 • 781 citations

TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis

1997 • 666 citations

Human lung carcinomas express Fas ligand.

1997 • 395 citations

Progress in understanding the molecular pathogenesis of human lung cancer

1998 • 291 citations

Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape

2000 • 256 citations

Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1

1999 • 245 citations

Expression of mage genes by non‐small‐cell lung carcinomas

1994 • 230 citations

A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer

1996 • 196 citations

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer

1996 • 186 citations

Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.

1995 • 178 citations

A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas

1996 • 127 citations

Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.

2000 • 108 citations

Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas.

1989 • 108 citations

CD133 expression: a potential prognostic marker for non-small cell lung cancers

2013 • 107 citations

Expression of FAS (CD95/APO-1) and FAS ligand in lung cancer, its prognostic and predictive relevance

1999 • 103 citations

Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.

1997 • 91 citations

Prognostic significance of p53 andras p21 expression in nonsmall cell lung cancer

1995 • 81 citations

Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.

1998 • 75 citations

Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.

1991 • 74 citations

Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.

1998 • 65 citations

Structural and functional analysis of β2 microglobulin abnormalities in human lung and breast cancer

1996 • 64 citations

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.

1999 • 56 citations

Detection of mage‐4 protein in lung cancers

1995 • 50 citations

ESTABLISHMENT OF A NEW HUMAN UTERINE CERVICAL ADENOCARCINOMA CELL-LINE, SISO, AND ITS REACTIVITY TO ANTICANCER REAGENTS

1995 • 42 citations

Molecular basis for lack of expression of HLA class I antigens in human small-cell lung carcinoma cell lines

1996 • 42 citations

Prognostic significance of p27/KIP1 protein (p27) and Ki-67 growth fraction in non-small cell lung cancers (NSCLCs)

2000 • 32 citations

Bcl-2 Expression in Non-Small Cell Lung Cancers: Higher Frequency of Expression in Squamous Cell Carcinomas with Earlier pT Status

1999 • 30 citations

Altered retinoblastoma protein expression in nonsmall cell lung cancer

1997 • 7 citations